Stock Reviews – July 2022

Graphic by TheSimpleStockMarket.com

Here are my top three stock reviews that are outperforming the market this month. Let’s take a closer look at these companies and see why they could be a potential trade.

PepsiCo, Inc. – PEP

PepsiCo, Inc. is an American multinational food, snack, and beverage corporation headquartered in Harrison, New York.‌
‌‌Founded – 1965‌‌
‌‌‌‌Employees – 309,000‌‌
‌‌‌‌CEO – Ramon Laguarta

pepsico.com

PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles.

The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets.

In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks.

Source: Google Finance as of July 8, 2022

PEP vs. S&P 500

I use the S&P 500 Index as the benchmark to compare any stock I’m reviewing. If the stock outperforms the index consistently, I will consider it for a trade.‌‌

As of July 8, 2022

1-Year Return‌‌

Source: Google Finance as of July 8, 2022

6-Month Return‌‌

Source: Google Finance as of July 8, 2022

1-Month Return‌‌

Source: Google Finance as of July 8, 2022

Is PEP a good investment right now?

As of July 8, 2022, PEP stock price climbed to $171.88 with 3,483,014 million shares trading. PEP has a market cap of $237.79 billion. This is considered a Mega Cap stock.

Last quarter Pepsico reported $16 billion in Revenue and $1.29 earnings per share. This beat revenue expectation by $670 million and exceeded earnings estimates by $.06.

PEP has outperformed the market in the last year with a price return of +17.7% while the SPY ETF lost -9.2%. PEP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +0.3% and +4.7%, respectively, while the SPY returned -13.0% and +2.8%, respectively.


Cigna Corp – CI

Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut.‌
‌‌Founded – 1982‌‌
‌‌‌‌Employees – 72,963‌
‌‌‌‌CEO – David Cordani

cigna.com

Cigna primarily provides pharmacy benefit management (PBM) and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers.

Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage.

The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.‌

Source: Google Finance as of July 8, 2022

CI vs. S&P 500

I use the S&P 500 Index as the benchmark to compare any stock I’m reviewing. If the stock outperforms the index consistently, I will consider it for a trade.‌‌

As of July 8, 2022

1-Year Return‌‌‌

Source: Google Finance as of July 8, 2022

6-Month Return‌‌‌

Source: Google Finance as of July 8, 2022

1-Month Return‌‌

Source: Google Finance as of July 8, 2022

‌Is CI a good investment right now?

As of July 8, 2022, CI stock price climbed to $279.19 with 2,325,235 million shares trading. CI has a market cap of $88.58 billion. This is considered a Large Cap stock. Last quarter Cigna reported $44 billion in Revenue and $6.01 earnings per share. This beat revenue expectation by $698 million and exceeded earnings estimates by $.83.

CI has outperformed the market in the last year with a price return of +20.1% while the SPY ETF lost -9.2%. CI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.9% and +7.5%, respectively, while the SPY returned -13.0% and +2.8%, respectively.


UnitedHealth Group Inc – UNH

UnitedHealth Group Incorporated is an American multinational managed healthcare and insurance company based in Minnetonka, Minnesota.‌
‌‌Founded – 1977‌‌
‌‌‌‌Employees – 350,000‌‌
‌‌‌‌CEO – Andrew Witty
unitedhealthgroup.com

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021.

As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care.

Along with its insurance assets, UnitedHealth’s continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.‌

Source: Google Finance as of July 8, 2022

UNH vs. S&P 500

I use the S&P 500 Index as the benchmark to compare any stock I’m reviewing. If the stock outperforms the index consistently, I will consider it for a trade.

As of July 8, 2022

1-Year Return‌‌

Source: Google Finance as of July 8, 2022

6-Month Return

Source: Google Finance as of July 8, 2022

‌‌1-Month Return‌‌

Source: Google Finance as of July 8, 2022

‌Is UNH a good investment right now?

As of July 8, 2022, UNH stock price climbed to $518.63 with 3,092,242 million shares trading. UNH has a market cap of $486.97 billion. This is considered a Mega Cap stock. Last quarter Unitedhealth Group Common (De) reported $80 billion in Revenue and $5.49 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $.12.

UNH has outperformed the market in the last year with a price return of +27.4% while the SPY ETF lost -9.2%. UNH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -3.1% and +3.8%, respectively, while the SPY returned -13.0% and +2.8%, respectively.


Disclaimer‌‌‌‌
‌‌This content is intended to be used and must be used for information and education purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances.

For more from Ricardo Gutierrez, visit https://www.thesimplestockmarket.com/


Sponsored Stories

Sponsored Stories